285 related articles for article (PubMed ID: 25567117)
1. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
[TBL] [Abstract][Full Text] [Related]
2. Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.
Trivedi PJ; Bruns T; Cheung A; Li KK; Kittler C; Kumagi T; Shah H; Corbett C; Al-Harthy N; Acarsu U; Coltescu C; Tripathi D; Stallmach A; Neuberger J; Janssen HL; Hirschfield GM
J Hepatol; 2014 Jun; 60(6):1249-58. PubMed ID: 24548531
[TBL] [Abstract][Full Text] [Related]
3. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
5. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.
Kuiper EM; Hansen BE; Adang RP; van Nieuwkerk CM; Timmer R; Drenth JP; Spoelstra P; Brouwer HT; Kuyvenhoven JP; van Buuren HR;
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1495-502. PubMed ID: 21389798
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Suzuki A; Lymp J; Donlinger J; Mendes F; Angulo P; Lindor K
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):259-64. PubMed ID: 17174610
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis.
Caballería L; Parés A; Castells A; Ginés A; Bru C; Rodés J
Am J Gastroenterol; 2001 Apr; 96(4):1160-3. PubMed ID: 11316164
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.
Rong G; Wang H; Bowlus CL; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Chen Y; An L; Yang Y; Gershwin ME
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):132-41. PubMed ID: 25762349
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma in Primary Biliary Cholangitis.
Sy AM; Ferreira RD; John BV
Clin Liver Dis; 2022 Nov; 26(4):691-704. PubMed ID: 36270724
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
[TBL] [Abstract][Full Text] [Related]
12. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan.
Harada K; Hirohara J; Ueno Y; Nakano T; Kakuda Y; Tsubouchi H; Ichida T; Nakanuma Y
Hepatology; 2013 May; 57(5):1942-9. PubMed ID: 23197466
[TBL] [Abstract][Full Text] [Related]
13. Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
Harms MH; Lammers WJ; Thorburn D; Corpechot C; Invernizzi P; Janssen HLA; Battezzati PM; Nevens F; Lindor KD; Floreani A; Ponsioen CY; Mayo MJ; Dalekos GN; Bruns T; Parés A; Mason AL; Verhelst X; Kowdley KV; Goet JC; Hirschfield GM; Hansen BE; van Buuren HR;
Am J Gastroenterol; 2018 Feb; 113(2):254-264. PubMed ID: 29231188
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Silveira MG; Suzuki A; Lindor KD
Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
[TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.
Cavazza A; Caballería L; Floreani A; Farinati F; Bruguera M; Caroli D; Parés A
Hepatology; 2009 Oct; 50(4):1162-8. PubMed ID: 19585656
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
Floreani A; Biagini MR; Chiaramonte M; Milani S; Surrenti C; Naccarato R
Ital J Gastroenterol; 1993; 25(9):473-6. PubMed ID: 8123893
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hepatic decompensation in patients with primary biliary cirrhosis.
Shi TY; Zhang LN; Chen H; Wang L; Shen M; Zhang X; Zhang FC
World J Gastroenterol; 2013 Feb; 19(7):1111-8. PubMed ID: 23467321
[TBL] [Abstract][Full Text] [Related]
20. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
